Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highly purified hMG stimulation protocols and ICSI outcomes
PACTR202112652853611Phase 3Completed
- Sponsor
- T-Therapeutics
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of human menopausal gonadotrophin in female infertility (2 arms), sponsored by T-Therapeutics. Primary endpoint: Percentage of top quality embryos formation. Started Apr 2020; status: completed.
02
Drugs
human menopausal gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on PACTR202112652853611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112652853611.